Associate Professor, Medicine, Keck School of Medicine of the University of So California
Oncology
Dr. Jorge J. Nieva, MD
|
|
Give Review
Jorge Nieva is an expert in the field of Oncology. He went to medical school at University of California Irvine School of Medicine. University of California Irvine School of Medicine is ranked 45 in research and 62 in primary care medicine Jorge J. Nieva is also a published doctor. He has 43 publication published. The most recent publication is: Injuries in youth ice hockey: a pilot surveillance strategy. Jorge Nieva accepts Medicare.
Publications
- Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
- Circulating tumor microemboli diagnostics for patients with non-small-cell lung Cancer.
- Adrenal metastases in lung cancer: clinical implications of a mathematical model.
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung Cancer (START): a randomised, double-blind, phase 3 trial.
- An Observational Study of Circulating Tumor Cells and (18)F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer.
- Symptomatic reduction in free testosterone levels secondary to crizotinib use in male Cancer patients.
- Spreaders and sponges define metastasis in lung Cancer: A Markov chain mathematical model.
- Abiraterone in metastatic prostate Cancer without previous chemotherapy.
- Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their Disease.
- ERCC1 expression in circulating tumor Cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-sma...
- A pilot study of long-acting octreotide for symptomatic malignant ascites.
- A stochastic Markov chain model to describe lung Cancer growth and metastasis.
- Characterization of circulating tumor Cell aggregates identified in patients with epithelial tumors.
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast Cancers.
- High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung Cancer patients: a longitudinal analysis.
- Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung Cancer: a glimpse into lung Cancer biology.
- Intravenous delivery of a multi-mechanistic Cancer-targeted oncolytic poxvirus in humans.
- Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53.
- Cytomorphology of circulating coloRectal tumor cells:a small case series.
- Circulating tumor Cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type.
- The ratio of cholesterol 5,6-secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo.
- Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.
- Tissue factor activity is increased in a combined platelet and microparticle sample from Cancer patients.
- Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation.
- Understanding hairy cell Leukemia genetics.
- The clinical significance of circulating tissue factor in prostate Cancer.
- Case study of the morphologic variation of circulating tumor Cells.
- Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic Leukemia.
- AMG 531, a thrombopoiesis-stimulating protein, for Chronic ITP.
- Proatherogenic effects of the cholesterol ozonolysis proDucts, atheronal-A and atheronal-B.
- Elevated levels of oxidized cholesterol metabolites in Lewy body disease Brains accelerate alpha-synuclein fibrilization.
- High speed detection of circulating tumor Cells.
- Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway.
- SHP1 expression in bone marrow biopsies of myelodysplastic Syndrome patients: a new prognostic factor.
- The antibody-catalyzed water oxidation pathway--a new chemical arm to Immune defense?
- Metabolite-initiated protein misfolding may trigger Alzheimer's Disease.
- Cladribine activity in systemic mast Cell disease: application of biochemistry in the modern era of molecular biology.
- Evidence for ozone formation in human atherosclerotic arteries.
- Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell Leukemia.
- Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation.
- Entropy, complexity, and Markov diagrams for random walk Cancer models.
- Injuries in youth ice hockey: a pilot surveillance strategy.
Schools
University Of California Irvine College Of Medicine
University Calif
Scripps Clinic
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- Blue Choice Personal
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health
- First Health (Coventry Health Care) PPO
- GEHA
- Humana
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Meritain Health
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- PacificSource
- Pekin Insurance
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Scripps Clinic -
University of California San Diego -
University of California Irvine School of Medicine
Hospital
-
Huntington Memorial Hospital
Drug Facts
| NPI NUMBER | 1497717672 | |
| NPPES Provider LastName | NIEVA | |
| NPPES Provider FirstName | JORGE | |
| NPPES Provider ZIPCode | 900890177 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1446.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 82.0 | |
| Percent Opioid Claims | 5.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497717672 |
| Last Name Of The Provider | NIEVA |
| First Name Of The Provider | JORGE |
| View All |
Similar Doctors
|
Dr. James M. Burke, MD |
|
|
Dr. Roy R. Hall, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger H. Halterman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alaa Muslimani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin K. Lucas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Troy A. Fiddler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brock P. Whittenberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela A. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thomas Purcell, MD |
|
|
Dr. Benjamin T. Marchello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick W. Cobb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kim M. Fehir, MD
This Doctor is OpenDoctor Recommended.
|